|Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties|
S Wilkening, F Stahl, A Bader
Drug metabolism and disposition 31 (8), 1035-1042, 2003
|Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21|
A Tenesa, SM Farrington, JGD Prendergast, ME Porteous, M Walker, ...
Nature genetics 40 (5), 631-637, 2008
|MDM2 SNP309 and cancer risk: a combined analysis|
S Wilkening, JL Bermejo, K Hemminki
Carcinogenesis 28 (11), 2262-2267, 2007
|Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2|
S Wilkening, A Bader
Journal of biochemical and molecular toxicology 17 (4), 207-213, 2003
|An efficient method for genome-wide polyadenylation site mapping and RNA quantification|
S Wilkening, V Pelechano, AI Järvelin, MM Tekkedil, S Anders, V Benes, ...
Nucleic acids research 41 (5), e65-e65, 2013
|Alternative polyadenylation diversifies post‐transcriptional regulation by selective RNA–protein interactions|
I Gupta, S Clauder‐Münster, B Klaus, AI Järvelin, RS Aiyar, V Benes, ...
Molecular systems biology 10 (2), 719, 2014
|Is there still a need for candidate gene approaches in the era of genome-wide association studies?|
S Wilkening, B Chen, JL Bermejo, F Canzian
Genomics 93 (5), 415-419, 2009
|The expression of HMGA genes is regulated by their 3′ UTR|
L Borrmann, S Wilkening, J Bullerdiek
Oncogene 20 (33), 4537-4541, 2001
|Quantitative real-time polymerase chain reaction: methodical analysis and mathematical model|
S Wilkening, A Bader
Journal of biomolecular techniques: JBT 15 (2), 107, 2004
|An Evaluation of High-Throughput Approaches to QTL Mapping in Saccharomyces cerevisiae|
S Wilkening, G Lin, ES Fritsch, MM Tekkedil, S Anders, R Kuehn, ...
Genetics 196 (3), 853-865, 2014
|SNP_tools: A compact tool package for analysis and conversion of genotype data for MS-Excel|
B Chen, S Wilkening, M Drechsel, K Hemminki
BMC research notes 2 (1), 1-4, 2009
|Interleukin promoter polymorphisms and prognosis in colorectal cancer|
S Wilkening, B Tavelin, F Canzian, K Enquist, R Palmqvist, A Altieri, ...
Carcinogenesis 29 (6), 1202-1206, 2008
|Genotyping 1000 yeast strains by next-generation sequencing|
S Wilkening, MM Tekkedil, G Lin, ES Fritsch, W Wei, J Gagneur, ...
BMC genomics 14 (1), 1-10, 2013
|Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case–control study …|
L Dossus, JD McKay, F Canzian, S Wilkening, S Rinaldi, C Biessy, ...
Carcinogenesis 29 (7), 1360-1366, 2008
|Determination of allele frequency in pooled DNA: comparison of three PCR-based methods|
S Wilkening, K Hemminki, R Kumar Thirumaran, J Lorenzo Bermejo, ...
Biotechniques 39 (6), 853-858, 2005
|The single nucleotide polymorphism IVS1+ 309 in mouse double minute 2 does not affect risk of familial breast cancer|
S Wilkening, JL Bermejo, B Burwinkel, R Klaes, CR Bartram, A Meindl, ...
Cancer research 66 (2), 646-648, 2006
|Negative feedback buffers effects of regulatory variants|
DM Bader, S Wilkening, G Lin, MM Tekkedil, K Dietrich, LM Steinmetz, ...
Molecular systems biology 11 (1), 785, 2015
|Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers|
P Peterlongo, J Chang-Claude, KB Moysich, A Rudolph, RK Schmutzler, ...
Cancer Epidemiology and Prevention Biomarkers 24 (1), 308-316, 2015
|No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin|
S Wilkening, K Hemminki, P Rudnai, E Gurzau, K Koppova, A Försti, ...
British Journal of Dermatology 157 (2), 375-377, 2007
|Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization|
HYT Yang, S Wilkening, MJ Iadarola
Neuroscience 103 (2), 493-502, 2001